Sunday, 11 October 20261:47 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

Biohaven strikes $100 million deal with Japan’s Ono Pharma for next-generation autoimmune disease drugs

Image: Indianpharmapost. Rights remain with the publisher.

Ono will secure exclusive rights to develop and commercialize Biohaven’s MoDE pan-IgG degrader portfolio in Japan, South Korea, Taiwan and the Association of Southeast Asian Nations (ASEAN) region

Read the full report on Indianpharmapost

Story file

Section
Health
First reported by
Indianpharmapost
Published
Sunday, 11 October 2026, 12:00 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Indianpharmapost with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all